Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
The Faces of Luminex: Molly Frazier, Marketing
With Luminex’s large workforce and active marketing department, you might imagine that there are loads of ongoing projects at any one time. This could quickly lead to chaos if it weren’t for Molly Frazier, Copywriter & Marketing Coordinator, who has been keeping the trains running on time since joining the company in 2016. She earned her bachelor’s degree from Sam Houston State University.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results
October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio
October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018
September 11
Luminex Corporation Declares Third Quarter Cash Dividend
September 6
Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands
